168 related articles for article (PubMed ID: 8428097)
21. Indications for gadolinium-DTPA in magnetic resonance evaluation of extracranial head and neck mass lesions: review of experience with 27 patients examined with a 2 tesla imager.
Chisin R; Gomori JM; Elidan J
Isr J Med Sci; 1992; 28(3-4):268-76. PubMed ID: 1592599
[TBL] [Abstract][Full Text] [Related]
22. [Use of magnevist in the clinical practice (clinical trials].
Cheremisin VM; Miakotin LL; Kovelenov AG; Trushchenko SG
Vestn Rentgenol Radiol; 1994; (4):22-5. PubMed ID: 7785194
[No Abstract] [Full Text] [Related]
23. Basic physics of MR contrast agents and maximization of image contrast.
Hendrick RE; Haacke EM
J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
[TBL] [Abstract][Full Text] [Related]
24. Dynamic contrast-enhanced MR imaging of the upper abdomen: enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer.
Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW
Magn Reson Med; 1994 Nov; 32(5):622-8. PubMed ID: 7808263
[TBL] [Abstract][Full Text] [Related]
25. Strategies for differential enhancement of myocardial ischemia using echoplanar imaging.
Wendland MF; Saeed M; Higgins CB
Invest Radiol; 1991 Nov; 26 Suppl 1():S236-8; discussion S245-7. PubMed ID: 1808137
[No Abstract] [Full Text] [Related]
26. Gadolinium-DTPA enhanced dynamic MR imaging in the evaluation of cisplatinum nephrotoxicity.
Frank JA; Choyke PL; Girton ME; Austin HA; Sievenpiper C; Inscoe SW; Black JL; Carvlin MJ; Dwyer AJ
J Comput Assist Tomogr; 1989; 13(3):448-59. PubMed ID: 2723175
[TBL] [Abstract][Full Text] [Related]
27. Gadolinium-DTPA-enhanced magnetic resonance imaging in intractable partial epilepsy.
Cascino GD; Hirschorn KA; Jack CR; Sharbrough FW
Neurology; 1989 Aug; 39(8):1115-8. PubMed ID: 2503770
[TBL] [Abstract][Full Text] [Related]
28. Thalamic hydatid cyst: contrast-enhanced MR imaging findings.
Sener RN
Comput Med Imaging Graph; 1996; 20(5):395-8. PubMed ID: 9007367
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging with gadolinium-DTPA enhancement in the differentiation of benign from neoplastic cord cavitation.
Clarke CE; Hawnaur J; Prvulovich E; Yuill GM; Bannister CM
Clin Radiol; 1990 Mar; 41(3):214-6. PubMed ID: 2323169
[TBL] [Abstract][Full Text] [Related]
30. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients.
Kinkel K; Tardivon AA; Soyer P; Spatz A; Lasser P; Rougier P; Vanel D
Radiology; 1996 Aug; 200(2):453-8. PubMed ID: 8685341
[TBL] [Abstract][Full Text] [Related]
31. Conspicuity of normal and pathologic female pelvic anatomy: comparison of gadolinium-enhanced T1-weighted images and fast spin echo T2-weighted images.
Troiano RN; Lange RC; McCarthy S
J Comput Assist Tomogr; 1996; 20(6):871-7. PubMed ID: 8933784
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
33. MR imaging of transverse myelitis using Gd-DTPA.
Pardatscher K; Fiore DL; Lavano A
J Neuroradiol; 1992; 19(1):63-7. PubMed ID: 1564531
[TBL] [Abstract][Full Text] [Related]
34. Benign and malignant gynecologic disease: clinical importance of fluid and peritoneal enhancement in the pelvis at MR imaging.
Outwater EK; Siegelman ES; Wilson KM; Mitchell DG
Radiology; 1996 Aug; 200(2):483-8. PubMed ID: 8685345
[TBL] [Abstract][Full Text] [Related]
35. In vivo fluorine-19 MR imaging: relaxation enhancement with Gd-DTPA.
Lee H; Price RR; Holburn GE; Partain CL; Adams MD; Cacheris WP
J Magn Reson Imaging; 1994; 4(4):609-13. PubMed ID: 7949689
[TBL] [Abstract][Full Text] [Related]
36. Non-T1-weighted spin-echo MR imaging with contrast material: experimental and preliminary clinical assessment.
Mihara F; Gupta KL; Righi AM
Radiat Med; 1994; 12(5):209-12. PubMed ID: 7863024
[TBL] [Abstract][Full Text] [Related]
37. Gadolinium-DTPA-enhanced magnetic resonance scanning in cerebellopontine angle tumors.
Wayman JW; Dutcher PO; Manzione JV; Nelson CN; Kido DK
Laryngoscope; 1989 Nov; 99(11):1167-70. PubMed ID: 2811558
[TBL] [Abstract][Full Text] [Related]
38. Intracranial ganglioglioma: MR imaging.
Algra PR; Scheltens P; Barkhof F; Valk J
AJR Am J Roentgenol; 1990 Oct; 155(4):899-900. PubMed ID: 2119137
[No Abstract] [Full Text] [Related]
39. Comparison of Gd-EOB-DTPA and Gd-DTPA for contrast-enhanced MR imaging of liver tumors.
Clemént O; Mühler A; Vexler VS; Kuwatsuru R; Berthezène Y; Rosenau W; Brasch RC
J Magn Reson Imaging; 1993; 3(1):71-7. PubMed ID: 8428104
[TBL] [Abstract][Full Text] [Related]
40. Contrast enhancement for the abdomen and pelvis.
Mitchell DG
Eur Radiol; 1997; 7 Suppl 5():238-42. PubMed ID: 9370550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
